JME Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1996) 17, 31-43    DOI: 10.1677/jme.0.0170031
© 1996 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, K J
Right arrow Articles by Howell, S L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, K J
Right arrow Articles by Howell, S L

Identification and localisation of a type IV cytosolic phospholipase A2 in rat pancreatic β-cells

K J Parker, P M Jones, C H Hunton, S J Persaud, C G Taylor and S L Howell

The liberation of arachidonic acid (AA), by phospholipase A2 (PLA2), is the rate-limiting step in a number of cell signalling pathways. In the pancreatic β-cell, AA itself is thought to participate in the regulation of insulin secretion. Recently a Ca2+-sensitive, AA-selective cytosolic PLA2 (type IV cPLA2) has been isolated from the human monocyte U937 cell line. Although the DNA sequence of this enzyme implies a molecular weight of 85 kDa, the protein migrates with a molecular weight of 100-110 kDa on SDS-PAGE. In many cell types, cPLA2s which are reactive towards antibodies raised against the type IV cPLA2 have been shown to hydrolyse AA from membrane glycerophospholipids. Using a polyclonal antibody raised against a recombinant form of type IV cPLA2, we have detected an immunoreactive protein with a molecular weight of 93·5 kDa in rat islets of Langerhans. Furthermore, we have detected similar immunoreactive proteins in insulin-secreting β-cell lines and have shown co-expression of type IV cPLA2 immunoreactivity and insulin immunoreactivity in rat pancreatic β-cells. Under non-stimulatory conditions the 93·5 kDa immunoreactive protein detected in rat islets of Langerhans was located predominantly in the cytosolic fraction. We have shown that immunoprecipitation of the rat immunoreactive protein from rat islet homogenates significantly decreases the total dithiothreitol/β-mercaptoethanol-insensitive PLA2 activity by 56·4±7% This provides further evidence that the immunoreactive rat protein is a type IV cPLA2 and is responsible for a large component of the PLA2 activity in rat islets of Langerhans. It is possible that, in the rat β-cell, type IV cPLA2 couples the increase in intracellular Ca2+, brought about by insulin secretagogues, to the liberation of AA and the subsequent release of insulin.




This article has been cited by other articles:


Home page
DiabetesHome page
S. J. Persaud, D. Muller, V. D. Belin, I. Kitsou-Mylona, H. Asare-Anane, A. Papadimitriou, C. J. Burns, G. C. Huang, S. A. Amiel, and P. M. Jones
The Role of Arachidonic Acid and Its Metabolites in Insulin Secretion From Human Islets of Langerhans
Diabetes, January 1, 2007; 56(1): 197 - 203.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. M. Milne, C. J. Burns, P. E. Squires, N. D. Evans, J. Pickup, P. M. Jones, and S. J. Persaud
Uncoupling of Nutrient Metabolism From Insulin Secretion by Overexpression of Cytosolic Phospholipase A2
Diabetes, January 1, 2005; 54(1): 116 - 124.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. M. Jones, C. J. Burns, V. D. Belin, H. M. Roderigo-Milne, and S. J. Persaud
The Role of Cytosolic Phospholipase A2 in Insulin Secretion
Diabetes, February 1, 2004; 53(90001): S172 - 178.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Juhl, M. Hoy, H. L. Olsen, K. Bokvist, A. M. Efanov, E. K. Hoffmann, and J. Gromada
cPLA2{alpha}-evoked formation of arachidonic acid and lysophospholipids is required for exocytosis in mouse pancreatic {beta}-cells
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E73 - E81.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. J. Persaud, H. M. Roderigo-Milne, P. E. Squires, D. Sugden, C. P.D. Wheeler-Jones, P. J. Marsh, V. D. Belin, M. J. Luther, and P. M. Jones
A Key Role for {beta}-Cell Cytosolic Phospholipase A2 in the Maintenance of Insulin Stores But Not in the Initiation of Insulin Secretion
Diabetes, January 1, 2002; 51(1): 98 - 104.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Gilon and J.-C. Henquin
Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic {beta}-Cell Function
Endocr. Rev., October 1, 2001; 22(5): 565 - 604.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. M. Jones and S. J. Persaud
Protein Kinases, Protein Phosphorylation, and the Regulation of Insulin Secretion from Pancreatic {beta}-Cells.
Endocr. Rev., August 1, 1998; 19(4): 429 - 461.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Society for Endocrinology.